LOADING
Comparing JPMorgan Chase (JPM) and Thermo Fisher Scientific (TMO) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JPM | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $916.3B | $213.3B |
| P/E Ratio | 15.1 | 30.9 |
| Forward P/E | 14.8 | 22.9 |
| PEG Ratio | 1.72 | 1.87 |
| EPS | $23.32 | $18.61 |
| Revenue Growth (YoY) | 30.4% | 10.5% |
| Profit Margin | 34.9% | 15.0% |
| Return on Equity | 17.8% | 13.5% |
| Dividend Yield | 1.71% | 0.31% |
| Beta | 0.98 | 0.85 |
| 52-Week High | $363.00 | $642.71 |
| 52-Week Low | $276.44 | $434.83 |
| Volume | -- | -- |
JPMorgan Chase is the larger company by market capitalization. JPMorgan Chase trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. JPMorgan Chase offers a higher dividend yield for income investors. JPMorgan Chase has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.